Meet Affinity^® and Novachor^®

the only fresh placental allografts for wound healing support.^1-4

Introducing the Organogenesis Fresh Family

Affinity and Novachor—human placental allografts composed of fresh, unaltered amnion and chorion membrane. Never dehydrated or frozen, Affinity and Novachor are uniquely preserved in a fresh state, making them the closest choices to native tissue.^1,5-11

Affinity and Novachor retain the placental tissue's native three-dimensional extracellular matrix (ECM) scaffold, growth factors, and endogenous, living cells.^1,5-11 As protective barriers and ECM scaffolds, Novachor and Affinity support the body’s inherent healing process.^1,12-14

Support an optimal environment for wound healing with Affinity and Novachor.^12-14

Placental tissue products start from the same raw material, but different preservation and processing techniques can drastically impact product characteristics.^10,15

AlloFresh is a gentle, proprietary technology that^1,6-11,16

For additional details, talk to an Organogenesis Tissue Regeneration Specialist today.

References: 1. McQuilling JP, et al. Int Wound J. 2017;14(6):993-1005. 2. Data on file. Nov_DR-0002. Organogenesis Inc. 3. Brantley JN, et al. Adv Wound Care. 2015;4(9):545-559. 4. Data on file. DR-0010. Organogenesis Inc. 5. Data on file. DR-0006. Organogenesis Inc. 6. Data on file. Nov_DR-0007. 7. Data on file. AF_DR-0013. Organogenesis Inc. 8. Data on file. Nov_DR-0005. Organogenesis Inc. 9. Data on file. DR-0007. Organogenesis Inc. 10. Data on file. Nov_DR-0001. Organogenesis Inc. 11. Data on file. AF_DR-0014. Organogenesis, Inc. 12. Allograft Tissue Information and Affinity. Instructions for Use. Canton, MA: Organogenesis Inc; 2021. 13. Allograft Tissue Information and Novachor. Instructions for Use. Canton, MA: Organogenesis Inc; 2021. 14. Serena TE, et al.  J Comp Eff Res. 2019. doi:10.2217/cer-2019-0142 15. Data on file. AF_DR-0011. Organogenesis Inc. 16. Data on file. DR-0005. Organogenesis Inc.

Please see complete prescribing information for Affinity here and for Novachor here.

©2024 Organogenesis Inc. OI-NOV1006_Rev2  04/2026
All rights reserved.
Affinity and Novachor are registered trademarks of Organogenesis Inc. 
AlloFresh is a trademark of Organogenesis Inc.

This site is intended for U.S. healthcare providers.

Keeping cells viable with AlloFresh™

Affinity

Helping non-healing wounds move to closed

In a randomized controlled trial in diabetic foot ulcers (DFUs, N=76), Affinity, as a protective barrier and ECM scaffold for wounds, resulted in¹⁴: 

60%

of DFUs closed at 12 weeks with Affinity compared to 38% with SOC* (P=0.04)

Novachor maintains native tissue architecture and is significantly thicker vs dehydrated chorion and native amnion^5,15

Considering native chorion for deeper wounds

Novachor

~4.2x thicker

vs dehydrated chorion¹⁰

*SOC=standard of care; included debridement, infection elimination, dressing, and offloading by total contact casting.

5

Q4194

857877005436

UPC number

HCPCS code

Billable units

Total size (cm²)

Product description

Product number